Pharming announces positive interim analysis data from open-

/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces data, including new evidence, from an...

Related Keywords

Netherlands , National Institutes Of Health , Maryland , United States , United Kingdom , London , City Of , Amsterdam , Noord Holland , America , American , V Koneti Rao , Ethan Metelenis , Heather Robertson , Michael Levitan , Virgil Dalm , Dan Caley , Anurag Relan , Linkedin , Vp Investor Relations Corporate Communications , Drug Administration , Nasdaq , Exchange Commission , Meeting Of The American Society Hematology , Pharming Groupnv , European Union , European Medicines Agency , Pharming Group , Lifespring Life Sciences Communication , Committee For Medicinal Products Human Use , Investor Relations Corporate Communications , Koneti Rao , Primary Immune Deficiency Clinic , National Institutes , American Society , Principal Investigator , Consultant Clinical Immunology , Immunoglobulin Replacement Therapy , Chief Medical Officer , New Drug Application , Prescription Drug User Fee Act , Marketing Authorisation Application , Medicinal Products , Human Use , Activated Phosphoinositide , North America , Middle East , Annual Report , Allergy Clin , Rev Allergy , Investor Relations , Corporate Communications , Spring Life Sciences Communication ,